BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li C, Chen Q, Zhou Y, Niu Y, Wang X, Li X, Zheng H, Wei T, Zhao L, Gao H. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer. FASEB J 2020;34:13333-44. [PMID: 32816365 DOI: 10.1096/fj.202000555R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen ACH, Huang W, Fong SW, Chan C, Lee KC, Yeung WSB, Lee YL. Hyperglycemia Altered DNA Methylation Status and Impaired Pancreatic Differentiation from Embryonic Stem Cells. Int J Mol Sci 2021;22:10729. [PMID: 34639069 DOI: 10.3390/ijms221910729] [Reference Citation Analysis]
2 Zhang Q, Xia T, Qi C, Du J, Ye C. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09180-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kundu S, Ali MA, Handin N, Conway LP, Rendo V, Artursson P, He L, Globisch D, Sjöblom T. Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis. J Exp Clin Cancer Res 2021;40:225. [PMID: 34233735 DOI: 10.1186/s13046-021-02025-2] [Reference Citation Analysis]
4 Lee H, Kwon Y, Jin H, Liu H, Kang W, Chun Y, Bae J, Choi H. Anticancer activity and metabolic profile alterations by ortho‐topolin riboside in in vitro and in vivo models of non‐small cell lung cancer. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202101333r] [Reference Citation Analysis]
5 Li Z, Geng J, Xie B, He J, Wang J, Peng L, Hu Y, Dai H, Wang C. Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway. Front Pharmacol 2022;13:834604. [DOI: 10.3389/fphar.2022.834604] [Reference Citation Analysis]
6 Hases L, Ibrahim A, Chen X, Liu Y, Hartman J, Williams C. The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers. Int J Mol Sci 2021;22:1354. [PMID: 33572952 DOI: 10.3390/ijms22031354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yan J, Huang YJ, Huang QY, Liu PX, Wang CS. Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells. Mol Carcinog 2022. [PMID: 35107180 DOI: 10.1002/mc.23393] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Han F, Zhang L, Liao S, Zhang Y, Qian L, Hou F, Gong J, Lai M, Zhang H. The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis. Oncogene 2021. [PMID: 34802034 DOI: 10.1038/s41388-021-02116-6] [Reference Citation Analysis]
9 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang Y, Yang X, Zhu XL, Bai H, Wang ZZ, Zhang JJ, Hao CY, Duan HB. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. Aging (Albany NY) 2021;13:15459-78. [PMID: 34148033 DOI: 10.18632/aging.203103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen Y, Wang C, Song J, Xu R, Ruze R, Zhao Y. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer. Front Immunol 2021;12:758004. [PMID: 34887861 DOI: 10.3389/fimmu.2021.758004] [Reference Citation Analysis]